Highlights

  • Alcidion Group Ltd (ASX: ALC) traded at $0.092 as at 3:00pm AEST on August 7, 2026.
  • The stock recorded a decline of approximately 1.61 percent for the session based on the data reviewed.
  • Shares traded within an intraday range of $0.091 to $0.094.
  • Market capitalisation stood at approximately $122.94 million.
  • Trading volume reached 145,456 shares during the session.

Alcidion Group Ltd (ASX: ALC) shares were trading at $0.092 as at 3:00pm AEST on August 7, 2026, after recording a decline of approximately 1.61 percent during the session. The stock traded within an intraday range of $0.091 to $0.094, while the broader S&P/ASX 200 Health Care Index moved lower during the same period.

Alcidion Share Price Movement on August 7, 2026

The data reviewed showed that Alcidion Group shares recorded a decline of approximately 1.61 percent for the session. The stock traded between an intraday low of $0.091 and a high of $0.094.

Daily share price movements can vary depending on company-specific developments, market participation and broader sector conditions. The movement during a single trading session represents a short-term view of market activity and is considered alongside historical performance and wider market trends.

Trading Volume and Market Capitalisation

Trading volume for Alcidion Group reached 145,456 shares during the session. Based on the reported share price, the company’s market capitalisation stood at approximately $122.94 million.

The trading activity reflected participation in the stock during the reviewed period, while the market capitalisation placed Alcidion among the smaller-capitalisation companies within the ASX health care technology segment.

One-Year Share Price Performance

Over the trailing one-year period, Alcidion Group recorded a decline of approximately 16.82 percent based on the data reviewed.

Health care technology companies can experience share price movements influenced by company-specific developments, contract-related updates, technology sector sentiment and broader market conditions. Individual company performance may differ from wider sector movements.

ASX Health Care Sector Performance

The broader S&P/ASX 200 Health Care Index (XHJ) was trading at 28,010.8 points, down 224.7 points or 0.80 percent, as at 3:20pm AEST on August 7, 2026, with the market session still open.

The index traded within an intraday range of 27,808.8 to 28,235.5 points against a previous close of 28,235.5. Over the past 52 weeks, the index ranged between 21,947.2 and 45,579.6 points, with a one-year return of negative 37.37 percent.

Individual health care stocks can move differently from the broader index due to company-specific factors, trading volumes and changes in market participation.

About Alcidion Group Ltd

Alcidion Group Ltd is an Australian health care technology company listed on the ASX under the ticker code ALC and classified within the health care sector.

The company operates within the digital health and software segment, where share price movements can be influenced by company updates, technology sector conditions and broader health care market sentiment.

Understanding the Trading Data

The share price, trading volume and market capitalisation figures provide an overview of Alcidion Group’s market activity during the reviewed session.

Trading volume represents the number of shares exchanged during the period, while market capitalisation reflects the market value based on the reported share price and shares on issue. A single trading session provides a snapshot of market activity and does not necessarily represent a longer-term trend.

Conclusion

As at 3:00pm AEST on August 7, 2026, Alcidion Group Ltd (ASX: ALC) shares were trading at $0.092, within a day range of $0.091 to $0.094, on trading volume of 145,456 shares and a market capitalisation of approximately $122.94 million.

The stock recorded a decline of approximately 1.61 percent during the session, while the broader S&P/ASX 200 Health Care Index also traded lower. The reviewed data provides an overview of Alcidion Group’s share price activity and position within the ASX health care technology segment.